GAP: The Genetic and Affective Prediction Study

Sponsor
St. Olavs Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02625818
Collaborator
Norwegian University of Science and Technology (Other)
400
1
60
6.7

Study Details

Study Description

Brief Summary

A major proportion of patients admitted to psychiatric acute and emergency departments have symptoms, behaviors or function influenced by implicit or explicit suicidal intention (tendency towards self-harm, or suicide attempt). There is an increased risk of suicide in the acute phase during in-patient stay and after discharge. At present there is no satisfactory tool to predict post-discharge suicide risk.

Multidimensional rating is expected to have better predictive properties than one-dimensional rating for suicidal behavior during in -patient stay and two years after discharge. Multidimensional rating assesses anxiety, panic, agitation, suicidal thoughts and ideations, as well as therapist's reactions during interviews. In the present study the predictive properties of two rating scales for suicidal behavior during in-patient stay and two years after will be compared. One of these is a multidimensional scale: "Multidimensional Assessment of Suicide Risk" (MARIS).

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    400 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    The Genetic and Affective Prediction Study
    Actual Study Start Date :
    Jan 1, 2016
    Actual Primary Completion Date :
    Jan 1, 2020
    Actual Study Completion Date :
    Jan 1, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    acute psychiatric condition

    Outcome Measures

    Primary Outcome Measures

    1. self-inflicted, potentially injurious behavior with intention to die defined as acts needing attendance by physician [2 weeks]

      during in-patient stay

    Secondary Outcome Measures

    1. suicide [2 years after discharge]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • acute agitated condition

    • informed consent

    Exclusion Criteria:
    • Drug abuse

    • in-patient stay for a fixed time at regular intervals

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 St Olavs Hospital, Østmarka psychiatric department Trondheim Norway

    Sponsors and Collaborators

    • St. Olavs Hospital
    • Norwegian University of Science and Technology

    Investigators

    • Study Director: Randolf Terje Vågen, St Olavs Hospital, Division of Mental Health Care
    • Study Director: Nanna Sønnichsen Kayed, Department of Mental Health, Faculty of Medicine and Health, NTNU

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    St. Olavs Hospital
    ClinicalTrials.gov Identifier:
    NCT02625818
    Other Study ID Numbers:
    • 2014/1751
    First Posted:
    Dec 9, 2015
    Last Update Posted:
    Apr 1, 2021
    Last Verified:
    Mar 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by St. Olavs Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 1, 2021